Παρακολούθηση
Claudia Cava
Claudia Cava
IBFM-CNR
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ibfm.cnr.it
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
A Colaprico, TC Silva, C Olsen, L Garofano, C Cava, D Garolini, ...
Nucleic acids research 44 (8), e71-e71, 2016
26912016
MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer
G Bertoli, C Cava, I Castiglioni
Theranostics 5 (10), 1122, 2015
8172015
MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer
G Bertoli, C Cava, I Castiglioni
International journal of molecular sciences 17 (3), 421, 2016
1612016
In silico discovery of candidate drugs against Covid-19
C Cava, G Bertoli, I Castiglioni
Viruses 12 (4), 404, 2020
1402020
Interpreting pathways to discover cancer driver genes with Moonlight
A Colaprico, C Olsen, MH Bailey, GJ Odom, T Terkelsen, TC Silva, ...
Nature communications 11 (1), 69, 2020
772020
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
L Cantini, G Bertoli, C Cava, T Dubois, A Zinovyev, M Caselle, ...
Nucleic acids research 47 (5), 2205-2215, 2019
772019
Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition
C Cava, G Bertoli, M Ripamonti, G Mauri, I Zoppis, PAD Rosa, MC Gilardi, ...
PloS one 9 (5), e97681, 2014
702014
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential
C Cava, G Bertoli, I Castiglioni
BMC systems biology 9, 1-36, 2015
612015
SpidermiR: an R/bioconductor package for integrative analysis with miRNA data
C Cava, A Colaprico, G Bertoli, A Graudenzi, TC Silva, C Olsen, ...
International journal of molecular sciences 18 (2), 274, 2017
522017
Comparison of data-merging methods with SVM attribute selection and classification in breast cancer gene expression
VB Stefania Tommasi, Paolo Pannarale, Mirko Abbrescia, Claudia Cava
Lecture Notes in Computer Science (including subseries Lecture Notes in …, 2011
52*2011
Potential role of miRNAs as theranostic biomarkers of epilepsy
C Cava, I Manna, A Gambardella, G Bertoli, I Castiglioni
Molecular Therapy-Nucleic Acids 13, 275-290, 2018
402018
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis
C Cava, G Bertoli, A Colaprico, C Olsen, G Bontempi, I Castiglioni
BMC genomics 19 (1), 1-16, 2018
382018
Integrative analysis with Monte Carlo cross-validation reveals miRNAs regulating pathways cross-talk in aggressive breast cancer
A Colaprico, C Cava, G Bertoli, G Bontempi, I Castiglioni
BioMed research international 2015, 2015
382015
Circulating microRNAs as potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy: a pilot study
S De Benedittis, F Fortunato, C Cava, F Gallivanone, E Iaccino, ...
International Journal of Molecular Sciences 22 (2), 702, 2021
372021
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
G Bertoli, C Cava, C Diceglie, C Martelli, G Rizzo, F Piccotti, L Ottobrini, ...
Breast cancer research and treatment 161, 605-616, 2017
372017
Radiation-induced gene expression changes in high and low grade breast cancer cell types
V Bravatà, C Cava, L Minafra, FP Cammarata, G Russo, MC Gilardi, ...
International journal of molecular sciences 19 (4), 1084, 2018
322018
The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer
G Bertoli, C Cava, I Castiglioni
Scandinavian Journal of Clinical and Laboratory Investigation 76 (sup245 …, 2016
302016
Portrait of tissue-specific coexpression networks of noncoding RNAs (miRNA and lncRNA) and mRNAs in normal tissues
C Cava, G Bertoli, I Castiglioni
Computational and Mathematical Methods in Medicine 2019, 2019
292019
Integration of molecular docking and in vitro studies: A powerful approach for drug discovery in breast cancer
C Cava, I Castiglioni
Applied Sciences 10 (19), 6981, 2020
282020
Theranostic application of miR-429 in HER2+ breast cancer
C Cava, C Novello, C Martelli, AL Dico, L Ottobrini, F Piccotti, M Truffi, ...
Theranostics 10 (1), 50, 2020
282020
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20